Some Angiotensin Receptor Blockers More Potent Than Others
Different angiotensin receptor blockers (ARBs) have distinct potencies for suppressing adrenal β-Arrestin1 (βarr1)-dependent post-myocardial infarction (MI) hyperaldosteronism, according to a letter published in the Dec. 30 issue of the Journal of the American College of Cardiology.
For candidates that are interested in applying for an internship at MJH & Associates, please click here.
The Retail Prescription: The Nemesis Within
Daniel Brown, PharmD
Pharmacy’s Greatest Obstacle to Expanded Patient Care Roles
2014 Volume Number
Mental Recess
2014 Volume Number